These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1112 related items for PubMed ID: 6239587
1. Fibrinolysis--a review. Kane KK. Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587 [Abstract] [Full Text] [Related]
2. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH, Diamond SL. Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011 [Abstract] [Full Text] [Related]
3. [Mechanism of thrombolytic enzymes]. Matsuo O. Rinsho Ketsueki; 1993 Apr; 34(4):395-402. PubMed ID: 8510325 [Abstract] [Full Text] [Related]
4. Extrinsic plasminogen activator: a new principle in fibrinolysis. Lijnen HR. Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789 [Abstract] [Full Text] [Related]
5. [Laboratory control of fibrinolytic therapy]. Vinazzer H. Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Aug; 113(1-2):30-7. PubMed ID: 2427412 [Abstract] [Full Text] [Related]
6. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy. Collen D. J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213 [Abstract] [Full Text] [Related]
7. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy]. Veremeenko KN, Kizim AI. Vopr Med Khim; 1984 Feb; 30(5):13-22. PubMed ID: 6084892 [Abstract] [Full Text] [Related]
8. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O, Rijken DC, Collen D. Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339 [Abstract] [Full Text] [Related]
9. Fibrin-specific thrombolytic agents. Collen D. Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1791-8. PubMed ID: 3122317 [Abstract] [Full Text] [Related]
10. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. Glas-Greenwalt P, Kant KS, Allen C, Pollak VE. J Lab Clin Med; 1984 Dec 14; 104(6):962-76. PubMed ID: 6239000 [Abstract] [Full Text] [Related]
11. Advances in clinical fibrinolysis. Hessel LW, Kluft C. Clin Haematol; 1986 May 14; 15(2):443-63. PubMed ID: 2942332 [Abstract] [Full Text] [Related]
12. [The fibrinolytic system and its activators]. Seifried E. Z Gesamte Inn Med; 1993 May 14; 48(6-7):272-82. PubMed ID: 8333223 [Abstract] [Full Text] [Related]
13. [Thrombolytics and their use]. Alessi MC, Juhan-Vague I. Rev Prat; 1999 Oct 01; 49(15):1654-8. PubMed ID: 10581996 [Abstract] [Full Text] [Related]
14. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen. Wu JH, Diamond SL. J Clin Invest; 1995 Jun 01; 95(6):2483-90. PubMed ID: 7769094 [Abstract] [Full Text] [Related]
15. Activation of the fibrinolytic system. Robison AK, Collen D. Cardiol Clin; 1987 Feb 01; 5(1):13-9. PubMed ID: 3103919 [Abstract] [Full Text] [Related]
16. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Collen D, Lijnen HR. Thromb Haemost; 1995 Jul 01; 74(1):167-71. PubMed ID: 8578451 [Abstract] [Full Text] [Related]
17. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis. Marder VJ, Francis CW. Prog Hemost Thromb; 1984 Jul 01; 7():325-56. PubMed ID: 6241729 [No Abstract] [Full Text] [Related]
18. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model. Guimarães AH, Rijken DC. Thromb Haemost; 2004 Mar 01; 91(3):473-9. PubMed ID: 14983222 [Abstract] [Full Text] [Related]